FA
LLY icon

FSA Advisors’s Eli Lilly LLY Stock Holding History

FSA Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-469
Closed -$358K – 232
2025
Q3 		$358K Sell
469
-37
-7% -$27.5K 0.28% 99
2025
Q2 		$394K Sell
506
-41
-7% -$31.9K 0.32% 94
2025
Q1 		$452K Buy
547
+62
+13% +$51.6K 0.36% 88
2024
Q4 		$374K Sell
485
-339
-41% -$281K 0.46% 78
2024
Q3 		$736K Sell
824
-271
-25% -$244K 0.73% 39
2024
Q2 		$918K Buy
1,095
+445
+68% +$356K 0.96% 30
2024
Q1 		$506K Buy
+650
New +$463K 0.54% 60

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FSA Advisors's LLY Position: Q4 2025 in Review

FSA Advisors sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 469 shares — an estimated $358K sold.

FSA Advisors first reported a position in LLY in Q1 2024 and held it in 7 quarters. The position peaked at $918K in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • FSA Advisors reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • FSA Advisors sold 469 Eli Lilly shares in Q4 2025, an estimated $358K.
  • FSA Advisors first reported a position in Eli Lilly in Q1 2024 and held it in 7 quarters.
  • FSA Advisors's Eli Lilly position peaked at $918K in Q2 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on FSA Advisors's 13F filing for Q4 2025, filed 2 Feb 2026.